Pediatrix Medical Group (NYSE:MD) Raised to Strong-Buy at Wall Street Zen

Pediatrix Medical Group (NYSE:MD) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

Several other brokerages also recently weighed in on MD. Zacks Research raised shares of Pediatrix Medical Group to a “strong-buy” rating in a report on Monday, August 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Pediatrix Medical Group in a report on Saturday, September 27th. Leerink Partners upped their target price on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Finally, UBS Group upped their target price on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $16.79.

Pediatrix Medical Group Trading Up 2.8%

Shares of Pediatrix Medical Group stock opened at $17.52 on Friday. The company has a market capitalization of $1.53 billion, a P/E ratio of 13.58 and a beta of 1.26. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. The company has a fifty day moving average of $15.82 and a 200 day moving average of $14.41. Pediatrix Medical Group has a fifty-two week low of $11.59 and a fifty-two week high of $17.77.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.11. The company had revenue of $468.84 million during the quarter, compared to the consensus estimate of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. Pediatrix Medical Group’s quarterly revenue was down 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.34 EPS. On average, sell-side analysts anticipate that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

Institutional Trading of Pediatrix Medical Group

Several hedge funds have recently made changes to their positions in the business. Boston Partners raised its position in shares of Pediatrix Medical Group by 1.3% during the 1st quarter. Boston Partners now owns 1,981,889 shares of the company’s stock valued at $27,990,000 after buying an additional 25,536 shares in the last quarter. American Century Companies Inc. raised its position in Pediatrix Medical Group by 28.6% in the 2nd quarter. American Century Companies Inc. now owns 1,931,867 shares of the company’s stock worth $27,722,000 after purchasing an additional 430,029 shares during the period. Invesco Ltd. raised its position in Pediatrix Medical Group by 9.3% in the 1st quarter. Invesco Ltd. now owns 863,269 shares of the company’s stock worth $12,509,000 after purchasing an additional 73,157 shares during the period. Ameriprise Financial Inc. raised its position in Pediatrix Medical Group by 175.4% in the 2nd quarter. Ameriprise Financial Inc. now owns 744,473 shares of the company’s stock worth $10,683,000 after purchasing an additional 474,186 shares during the period. Finally, Qube Research & Technologies Ltd raised its position in Pediatrix Medical Group by 2.0% in the 2nd quarter. Qube Research & Technologies Ltd now owns 735,526 shares of the company’s stock worth $10,555,000 after purchasing an additional 14,596 shares during the period. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.